Epsilon Healthcare Ltd (ASX: EPN) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Epsilon Healthcare Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$7.21 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
300.35 million
Earnings per share
-0.011
Dividend per share
N/A
Year To Date Return
N/A
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Epsilon Healthcare Ltd (ASX: EPN)
Latest News
⏸️ Investing
Why the Auscann Group Holdings Ltd share price jumped 25% higher today
⏸️ Investing
Are the ASX pot stocks running out of puff?
⏸️ Investing
Medical marijuana stocks are smoking hot right now
⏸️ Investing
Why the Hydroponics Company Ltd share price rocketed 28% higher today
⏸️ Investing
What's the best ASX pot stock to buy?
⏸️ Investing
Australian pot stocks: November update
⏸️ Investing
The Hydroponics Company Ltd share price just flew off the charts
⏸️ Investing
Aussie pot stocks are on fire again
⏸️ Investing
Why Auscann Group Holdings Ltd shares are up 29% this week
⏸️ Investing
Aussie pot stocks go nuts: Here's what you need to know
⏸️ Investing
Why these 4 ASX shares started the week with strong gains
⏸️ Investing
Pot stock Hydroponics Company Ltd rockets 24% higher
EPN ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Epsilon Healthcare Ltd
Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 28 Sep 2023 | Alan Beasley | Buy | 50,000 | $1,563 |
On-market trade.
|
| 22 Sep 2023 | Alan Beasley | Buy | 2,543,822 | $67,433 |
On-market trade.
|
| 21 Sep 2023 | Alan Beasley | Buy | 3,300,000 | $85,800 |
Off-market trade.
|
| 12 Sep 2023 | Alan Beasley | Buy | 1,931,156 | $47,200 |
On-market trade.
|
| 30 Jun 2023 | Alan Beasley | Buy | 2,675,022 | $54,984 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Stuart Hamilton Cameron | Non-Executive Director | Oct 2022 |
Stuart is a Chartered Accountant having many years of experience dealing with listed public companies.
|
| Mr Alan Preston Beasley | Non-Executive DirectorNon-Executive Deputy Chairman | Aug 2016 |
Mr Beasley has worked in the Investment Banking and Investment Management Industries for over 30 years with BankersTrust Australia, Goldman Sacks Asset Management, BNP Paribas Asset Management Ltd. The last two positions as Managing Director and Australian Country Head. Mr Beasley is a Director and former Director of several listed and unlisted public and private companies including two public charities.
|
| Mr Xiao (Josh) Cui | Executive ChairmanExecutive Director | Oct 2022 |
Mr Cui is the Managing Director at Watercrest Capital, a global private investment firm specialising in managing alternative investments and dealing with multiple asset classes. Mr Cui manages private equity, energy resources, hedge funds, fixed income, forex exchange and real estate development. He currently holds an RG 146 Forex certificate and The Securities Qualification Certificate from SAC. Adiitionally, he has 10 years of experience as a professional investor specialising in generating investment returns by leveraging flexible investment strategies. He has been focused on primary market capital raising and PE investment not just in Australia, but also the Asia Pacific area. He also has experience in primary/secondary market investments, hedge fund and other entities, capital market fund raising, IPO and M&A.
|
| Mr Marcelo Mora | Company Secretary | Dec 2022 |
-
|
| Mr Peter Giannopoulos | Chief Executive Officer | May 2023 |
-
|
| Peter Giannopoulos | Chief Executive Officer |
-
|
|
| Marcelo Mora | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Watercrest Asset Management Pty Ltd | 35,828,878 | 11.93% |
| Fennell Church Pty Ltd | 8,438,499 | 2.81% |
| Mr Craig Graeme Chapman <Nampac Discretionary A/C> | 7,500,000 | 2.50% |
| Health360 Investment Management Inc | 7,052,880 | 2.35% |
| Cannim Group Pty Ltd | 5,555,556 | 1.85% |
| Filmrim Pty Ltd | 4,465,755 | 1.49% |
| Barcoo Holdings Pty Ltd <Wyan Family Investments> | 3,795,824 | 1.26% |
| Karantzias Investments Pty Ltd <Karantzias Family A/C> | 3,636,364 | 1.21% |
| Sckld Investments Pty Ltd <Sckld Holdings A/C> | 3,593,894 | 1.20% |
| Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> | 3,055,650 | 1.02% |
| Mr George Daaboul | 3,000,000 | 1.00% |
| Meta Growth Corp | 2,942,489 | 0.98% |
| Celtic Capital Pty Ltd | 2,888,872 | 0.96% |
| Tiger Pty Ltd <Tiger Commercial Unit Trust> | 2,545,455 | 0.85% |
| Barcoo Holdings Pty Ltd <Maple Ventures> | 2,438,341 | 0.81% |
| Htgr Investments Pty Ltd | 2,298,765 | 0.77% |
| Mrs Chongna Wang | 2,046,035 | 0.68% |
| Mr Alan Roseby Barkas + Mrs Lee Margaret Barkas <Barkas Super | 2,000,000 | 0.67% |
| Mr Craig Graeme Chapman <Nampac Discretionary A/C> (i) | 1,958,684 | 0.65% |
| Citicorp Nominees Pty Limited | 1,598,988 | 0.53% |
